Frank Beurskens, PhDDirector and Antibody Format Translation Lead at GenmabSpeaker
Profile
Frank Beurskens is Director and Antibody Format Translation Lead at Genmab, where he advances antibody engineering and therapeutic innovation. Since 2002, he has contributed to key research on complement system modulation, antibody structure-function, bacterial and tumor targeting. He holds multiple patents, including innovations in Fc-Fc interactions and hexameric antibody formats enhancing complement activation and immune efficacy.
Agenda Sessions
Complement Activation by IgG Subclasses is Governed By Their Ability to Oligomerize Upon Antigen Binding
, 3:00pmView Session